---
title: "HIPO: Q2 2026 GWP up 61% to $482M, with improved profitability and raised full-year guidance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294351276.md"
description: "GWP surged 61% year-over-year to $482M in Q2 2026, with revenue up 23% to $145M and net income at $21M. Combined ratio improved to 95.8%, and 2026 guidance was raised for GWP, revenue, and adjusted net income. Growth was driven by diversification and operational efficiency.Original document: Hippo Holdings Inc. [HIPO] Slides Release — Jul. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T11:04:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294351276.md)
  - [en](https://longbridge.com/en/news/294351276.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294351276.md)
generator: "portal-rs"
---

# HIPO: Q2 2026 GWP up 61% to $482M, with improved profitability and raised full-year guidance

GWP surged 61% year-over-year to $482M in Q2 2026, with revenue up 23% to $145M and net income at $21M. Combined ratio improved to 95.8%, and 2026 guidance was raised for GWP, revenue, and adjusted net income. Growth was driven by diversification and operational efficiency.

Original document: Hippo Holdings Inc. \[HIPO\] Slides Release — Jul. 30 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [HIPO.US](https://longbridge.com/en/quote/HIPO.US.md)
- [HIPOW.US](https://longbridge.com/en/quote/HIPOW.US.md)

## Related News & Research

- [Hippo Holdings’ Spinnaker CEO Torben Ostergaard sells USD 82,208 of common shares](https://longbridge.com/en/news/296277326.md)
- [SoftwareOne attaches full H1 2026 report in correction to earlier release](https://longbridge.com/en/news/297010247.md)
- [Cemat publishes H1 2026 interim report](https://longbridge.com/en/news/297006906.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)
- [Equifax declares Q3 2026 distribution of R$ 2.02 per unit, payable Sept. 22](https://longbridge.com/en/news/296941296.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**